|
|
| Resumen de los artículos 2010 - 2011 |
- |
|
|
|
Artículos científicos
La mayoría de los resúmenes de artículos presentes en esta sección han sido redactados por la escritora científica del EHDN, Diana Raffelsbauer, a petición del Comité Editorial del Boletín del EHDN.
El Grupo Europeo pretende informar a las personas interesadas en la enfermedad y a la comunidad de profesionales de la salud sobre los esfuerzos actuales y los logros conseguidos para encontrar una cura para la enfermedad de Huntington.
| Comprehensive behavioral
testing in the R6/2 mouse model
of Huntington’s disease shows no
benefit from CoQ10 or minocyclineLiliana B. Menalled et al.  am01-jan2011-issue12-en A randomized, placebocontrolled
trial of latrepirdine
in Huntington‘s disease
Karl Kieburtz et al. am02-jan2011-issue12-en Cell loss in the motor and cingulate
cortex correlates with symptomatology
in Huntington’s diseaseDoris C. V. Thu et al. am03-jan2011-issue12-en Observing Huntington’s disease:
the European Huntington’s Disease
Network’s REGISTRY
Michael Orth and the European Huntington‘s Disease
Network am04-apr2011-issue13-en Biological and clinical changes
in premanifest and early stage
Huntington’s disease in the TRACKHD
study: the 12-month longitudinal
analysis
Sarah J. Tabrizi et al. am05-apr2011-issue13-en Matrix metalloproteinases
are modifiers
of huntingtin proteolysis
and toxicity in
Huntington’s disease
John P. Miller et al. am06-apr2011-issue13-en | | Early changes in
the hypothalamic
region in prodromal
Huntington
disease revealed
by MRI analysis
Charlotte Soneson et al. am08-jul2011-issue14-en An antisense CAG repeat transcript
at the JPH3 locus mediates
expanded polyglutamine protein
toxicity in Huntington‘s diseaselike
2 mice
Brian Wilburn et al. am09-jul2011-issue14-en Discrepancies in reporting
the CAG repeat lengths for
Huntington’s disease
Oliver Quarrell et al. am10-jan2012-issue15-en Functional gene expression
profiling in yeast implicates
translational dysfunction in
mutant huntingtin toxicity
Eran Tauber et al. am11-jan2012-issue15-en A natural antisense transcript at
the Huntington’s disease repeat
locus regulates HTT expression
Daniel W. Chung et al. am12-jan2012-issue15-en Pridopidine for the treatment of
motor function in patients with
Huntington’s disease (MermaiHD):
a phase 3, randomised, doubleblind,
placebo-controlled trial
Justo G. de Yébenes et al. am01-jan2012-issue15-en |
|
![[logo]](/html/hd_logo_web_re.gif){kind=logo}
![[+]](/public/pfeil_rechts.gif)
Enfermedad de Huntington